ArticleJournal of the anus, rectum and colon2026
Development and Validation of a Computer-Aided Diagnostic System for Colorectal Lesions Based on the JNET Classification: Supporting the "Resect and Discard" Strategy.
Article in Journal of the anus, rectum and colon, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Although the Japan NBI Expert Team (JNET) classification for colorectal lesions is clinically useful, standardization remains challenging owing to endoscopist variabilities. Therefore, we developed a computer-aided diagnosis (CADx) system to support JNET diagnoses, potentially facilitating a "Resect and Discard" strategy. The CADx system's diagnostic performance and its potential to support the "Resect and Discard" strategy were compared with those of endoscopists of varying experience. Methods: Forty-three patients (60 lesions) who underwent CADx system colonoscopies at Hiroshima University Hospital between September 2022 and July 2024 were evaluated. Endoscopists were grouped by experience: beginners (100-500 cases, n=4), intermediates (1,000-2,000 cases, n=5), and experts (>2,000 cases, n=3). In Study 1, JNET classification concordance between the CADx system and beginner/intermediate endoscopists was compared, using expert diagnosis as the gold standard. Study 2 included 38 <10 mm lesions, with histopathology as the gold standard. Lesions excluding advanced neoplasia were classified as "Resect and Discard". The CADx system and endoscopists were evaluated for identifying JNET Type 1 and 2A lesions as non-advanced neoplasia. Results: In Study 1, CADx-expert concordance was 83.3% (Kappa=0.75)-significantly higher than beginners (66.7%) and outperforming intermediates (78.0%). In Study 2, the CADx system's accuracy was 92.1%-significantly higher than beginners (70.4%) and outperforming intermediates (82.6%) and experts (78.9%). The CADx system's advanced neoplasia negative predictive value was 100%. Conclusions: The CADx system showed high concordance with expert diagnoses. For lesions <10 mm, its high advanced neoplasia diagnostic accuracy indicates its potential utility in supporting the "Resect and Discard" strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.